查找临床试验

已按「头颈癌」检索,对应国际通用词 head and neck cancer

试验不在中国怎么办?

共找到 601 项正在招募的试验(在中国/港澳台设有中心)

数据更新于 00:24,每 5 分钟自动同步
正在招募不适用中国有中心NCT06019455

The Level of Patient Participation in Lung and Esophageal Cancer Patients Treated With Definitive Radiochemotherapy.

China

年龄 18 Years – 75 Years

Sun Yat-sen University

正在招募不适用中国有中心NCT07326358

AI System for Anatomic Recognition & Lesion Detection in Nasopharyngolaryngoscopy: A Prospective Study

China

年龄 18 Years – 不限

Ruijin Hospital

正在招募II 期中国有中心NCT05941338

Tirelizumab in Combination With Carboplatin and Albumin-binding Paclitaxel for Neoadjuvant Therapy in HNSCC

China

年龄 18 Years – 65 Years

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

正在招募I 期 / II 期中国有中心NCT06780111

Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)

United States、Brazil、Chile、China、Czechia 等 12 国

年龄 18 Years – 不限

Merck Sharp & Dohme LLC

正在招募I 期 / II 期中国有中心NCT07367516

Clinical Trial Evaluating TQB6411 Injection in Participant s With Esophageal Cancer

China

年龄 18 Years – 75 Years

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

正在招募II 期中国有中心NCT07692204

A Dose Optimization/Expansion Study of SAR445877 in Adult Chinese Participants With Advanced Gastric or Gastroesophageal Junction Cancer

China

年龄 18 Years – 不限

Sanofi

正在招募I 期 / II 期中国有中心NCT05937438

Postoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal Carcinoma

China

年龄 18 Years – 75 Years

Anhui Provincial Hospital

正在招募II 期中国有中心NCT04807140

Neoadjuvant Toripalimab or Toripalimab in Combination With Carboplatin and Nab-paclitaxel in Untreated HNSCC (HNSCC-002)

China

年龄 18 Years – 80 Years

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

正在招募II 期中国有中心NCT06843889

A Phase II Study of Toripalimab Combined With Sequential Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell Carcinoma

China

年龄 18 Years – 75 Years

Nanfang Hospital, Southern Medical University

正在招募不适用中国有中心NCT07557225

18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors

China

年龄 18 Years – 不限

Peking University First Hospital

正在招募I 期 / II 期中国有中心NCT06385080

A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer

United States、China、France、Germany、Japan 等 11 国

年龄 18 Years – 不限

Janssen Research & Development, LLC

正在招募不适用中国有中心NCT05892354

Effect of Immunonutrients on Oral Mucositis in Nasopharyngeal Carcinoma Patients After Chemoradiotherapy

China

年龄 18 Years – 70 Years

First Affiliated Hospital of Guangxi Medical University